Martin Pulé
Founder chez AUTOLUS THERAPEUTICS PLC
Fortune : 4 M $ au 31/03/2024
Profil
Martin Pulé is the founder of Autolus Therapeutics Plc, where he currently holds the title of Chief Scientific Officer & Senior Vice President.
Autolus Therapeutics Plc was founded in 2014.
Dr. Pulé is also the founder of Autolus Ltd.
Dr. Pulé's education history includes an undergraduate degree from University College Dublin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0,42% | 01/03/2023 | 698 741 ( 0,42% ) | 4 M $ | 31/03/2024 |
Postes actifs de Martin Pulé
| Sociétés | Poste | Début |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Founder | 01/09/2014 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Founder | - |
Formation de Martin Pulé
| University College Dublin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
